MGA, a suppressor ofMYC, is recurrently inactivated in high risk chronic lymphocytic leukemia
Year: 2012
Type: article
Study design: Observational Study
Abstract: Although modern treatment strategies are highly effective in many cases of progressive chronic lymphocytic leukemia (CLL), a challenging subgroup of patients show poor response to standard regimens...
Authors: Lorenzo De Paoli, Michaela Cerri, Sara Monti, Silvia Rasi, Valeria Spina, Alessio Bruscaggin, Mariangela Greco, Carmela Ciardullo, Rosella Famà, Stefania Cresta, Rossana Maffei, Marco Ladetto, Maurizio Martini, Luca Laurenti, Francesco Forconi, Roberto Marasca, Luigi M. Larocca, Francesco Bertoni, Gianluca Gaidano, Davide Rossi
Institutions: Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, University of Modena and Reggio Emilia, University of Turin, Università Cattolica del Sacro Cuore, University of Siena, University of Southampton, Institute of Oncology Research, Istituto Oncologico della Svizzera Italiana
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2162133018
